Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

JAK Kinase Inhibition Abrogates STAT3 Activation and Head and Neck Squamous Cell Carcinoma Tumor Growth

Neoplasia(2015)10.1016/j.neo.2015.01.003Source: DataRank Database

JAK Kinase Inhibition Abrogates STAT3 Activation and Head and Neck Squamous Cell Carcinoma Tumor Growth is a research paper published in Neoplasia (2015). On theSindex it has a DataRank of 0.650. It has been cited 75 times.

N/A

0.650DataRank · unranked

Scored on demand from live citation data

75 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: goldTopics (73)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.650

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (11)

Netanya I. Pollock,John Black ORCID,Kara A. DeGrave,Sarah Wheeler ORCID,Maria L. Freilino

Live enrichment

PubMed:25810010 PMC:PMC4372647

NCI NIH HHS

Grant: R01 CA077308

NCI NIH HHS

Grant: P50CA097190

NCI NIH HHS

Grant: R01CA77308

National Institutes of Health

Grant: 5R01CA077308-05

STAT MEDIATED TGF ALPHA/EGFR SIGNALING IN SCCHN

National Institutes of Health

Grant: 5P50CA097190-10

Administrative Core

goldLicense: CC BY NC ND

publisherhttps://api.elsevier.com/content/article/PII:S1476558615000147?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1476558615000147?httpAccept=text/plain

Europe_PMChttps://europepmc.org/articles/PMC4372647

Europe_PMChttps://europepmc.org/articles/PMC4372647?pdf=render

https://doi.org/10.1016/j.neo.2015.01.003

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Cell Line, TumorAnimalsHumansMiceCarcinoma, Squamous CellHead and Neck NeoplasmsDisease Models, AnimalPyrazolesPyrimidinesRNA, MessengerAntineoplastic AgentsProtein Kinase InhibitorsTumor BurdenXenograft Model Antitumor AssaysSignal TransductionCell ProliferationGene ExpressionPhosphorylationGene DosageSTAT3 Transcription FactorJanus Kinase 2Janus Kinase 1Janus KinasesSquamous Cell Carcinoma of Head and Neck

Keywords

MessengerGene DosageGene ExpressionClinical sciencesMicePhosphorylationRC254-282CancerTumorNeoplasms. Tumors. Oncology. Including cancer and carcinogensTumor Burden5.1 PharmaceuticalsHead and Neck NeoplasmsCarcinoma, Squamous CellSignal TransductionSTAT3 Transcription FactorOncology and Carcinogenesis610Antineoplastic AgentsArticleCell LineRare DiseasesCell Line, Tumor616AnimalsHumansOncology & CarcinogenesisRNA, MessengerDental/Oral and Craniofacial DiseaseProtein Kinase InhibitorsCell ProliferationJanus KinasesBiomedical and Clinical SciencesAnimalSquamous Cell Carcinoma of Head and NeckCarcinomaJanus Kinase 1Janus Kinase 2Xenograft Model Antitumor AssaysDisease Models, AnimalOrphan DrugPyrimidinesSquamous CellDisease ModelsRNAPyrazoles

Sustainable Development Goals

SDG 3: 3. Good health

JAK Kinase Inhibition Abrogates STAT3 Activation and Head and Neck Squamous Cell Carcinoma Tumor Growth

FAIR Checklist

DataRank Breakdown

Authors (11)

Funding (5 grants)

Open Access

Topics